Homocysteine 12 µmol/L + MTHFR — the actionable methylation stack
A homocysteine of 12 µmol/L is above the optimal threshold of <8 µmol/L that the contemporary cardiovascular and cognitive research literature has converged on, though it's still inside many lab reference ranges (typically <15 µmol/L). Homocysteine is a sulphur-containing amino acid produced when methionine donates its methyl group; it's then either re-methylated back to methionine (using folate and B12) or trans-sulphurated to cysteine (using B6). With an MTHFR C677T variant — present in ~30–40% of European-descent populations — the enzyme that converts dietary folate to its active form (5-MTHF) is reduced in efficiency by 40–70%, so re-methylation is slower and homocysteine accumulates.
Reference ranges
| Optimal (research) | < 8 µmol/L |
| Acceptable | 8 – 12 µmol/L |
| Mildly elevated | 12 – 30 µmol/L |
| Moderately elevated | 30 – 100 µmol/L |
| Severe (genetic) | > 100 µmol/L |
What this marker measures
Plasma total homocysteine is a downstream readout of one-carbon metabolism — the network of methylation reactions that includes folate, B12, B6, choline, and methionine. The biology: methionine donates its methyl group → S-adenosylmethionine (SAM) → S-adenosylhomocysteine (SAH) → homocysteine. To regenerate methionine, the body either re-methylates homocysteine using 5-methyltetrahydrofolate (the product of MTHFR) and B12, or trans-sulphurates it to cysteine via B6. When any one of these inputs is limited (B-vitamin deficiency or genetic enzyme variant), homocysteine accumulates.
Why might it be elevated?
- ·Folate deficiency or MTHFR C677T/A1298C variants impairing 5-MTHF production
- ·B12 deficiency (often in older adults, vegans, or PPI users)
- ·B6 deficiency (rare in isolation)
- ·Renal insufficiency (kidney clears homocysteine)
- ·Hypothyroidism
- ·Methotrexate, anticonvulsants, metformin (long-term — depletes B12)
- ·Smoking and excessive caffeine
- ·High homocystinuria genetic variants (CBS deficiency — very rare, very high)
Why might it be low?
- ·Active correction with methylated B vitamins
- ·Pregnancy (homocysteine drops physiologically)
- ·Generally not a clinical concern when low
Compounds whose research literature has investigated this area
These are research-grade compounds in our catalogue whose published study literature touches the same biology. Listed for research context — not as recommendations for self-administration.
FAQ
Should I get MTHFR genotyped?+
If your homocysteine is elevated, yes — knowing your MTHFR status changes the supplementation strategy (methylated forms vs. standard folic acid). 23andMe and Ancestry data both expose MTHFR variants if you've already tested. NHS genotyping for MTHFR is not standard and typically requires private testing.
What's the supplementation stack the literature points to?+
For homocysteine elevation with confirmed MTHFR variant: methylfolate (5-MTHF, 400–800 mcg), methylcobalamin (B12, 500–1000 mcg), pyridoxal-5-phosphate (P5P, ~25 mg), trimethylglycine (TMG, 500–1000 mg). Trials like VISP and HOPE-2 lowered homocysteine reliably; whether the lowering reduced cardiovascular events is more contested. Discuss with a clinician — this is research-context information, not a recommendation.
Does my homocysteine need treating at 12?+
Whether intervention at this level meaningfully reduces hard endpoints (stroke, MI, dementia) is debated. The literature is more confident about elevations >15 µmol/L. However, the cost-of-correction is low (B vitamins are cheap and well-tolerated), so many longevity-oriented clinicians treat 8–15 as worth correcting opportunistically.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →